EUVIMEDEUVIMED entdecken
Crossref

Development of a predictive model for eosinophilia in patients treated with ampicillin/sulbactam or piperacillin/tazobactam

Sohyun Moon, Jimin Hong, Dae Hun Lee, Hye Su Kim, Ki Nam Nam, Yong Duk Jeon, Woorim Kim iD

British Journal of Clinical Pharmacology · 2025

DOI: 10.1002/bcp.70368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Sohyun Moon und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Kangwon National University, Chuncheon-si, Republic of Korea. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Piperacillin, Tazobactam Drug Combination, Eosinophilia, beta-Lactamase Inhibitors. Die Arbeit nennt 37 Literaturangaben. Gefördert von: 2024 Research Grant from Kangwon National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

We aim to identify risk factors for antibiotic‐induced eosinophilia in hospitalized patients receiving penicillin/beta‐lactamase inhibitor therapy and to develop a machine learning–enhanced predictive risk‐scoring model.

Methods

A retrospective cohort study was conducted involving 490 hospitalized patients treated with intravenous ampicillin/sulbactam or piperacillin/tazobactam. After applying eligibility criteria, 378 patients were included in the final analysis. Multivariate logistic regression was used to identify independent risk factors for eosinophilia, which were incorporated into a clinical risk‐scoring system. To improve predictive accuracy, machine learning models including elastic net regression were developed and evaluated using five‐fold cross‐validation. Model performance was assessed using the area under the receiver operating characteristic curve (AUROC).

Results

Among the 378 patients, 27 (7.1%) developed eosinophilia. Nine independent risk factors were identified: aminoglycosides, arrhythmias, chlorpheniramine maleate, glycopeptides, levetiracetam, polystyrene sulfonate, rheumatoid arthritis, stroke and ursodeoxycholic acid. The risk score ranged from 0 to 8, corresponding to predicted eosinophilia probabilities of 3.3% to 93.8% (AUROC = 0.787). Among the machine learning approaches tested, elastic net regression achieved the highest predictive performance.

Conclusion

This study proposes a clinically applicable risk‐scoring model for predicting eosinophilia in patients treated with penicillin/beta‐lactamase inhibitors. Incorporating machine learning improved model accuracy, enabling more precise identification of high‐risk patients. The model supports proactive risk assessment and may inform tailored monitoring and intervention strategies in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsPiperacillin, Tazobactam Drug CombinationEosinophiliabeta-Lactamase InhibitorsHumansMaleRetrospective StudiesFemaleSulbactamMiddle AgedAgedRisk FactorsAmpicillinMachine LearningAdultAged, 80 and overRisk Assessment

Stichwörter der Autor:innen

eosinophiliamachine learningpenicillin/beta‐lactamase inhibitorsrisk scoring model

Substanzen

SulbactamAnti-Bacterial AgentsPiperacillin, Tazobactam Drug CombinationAmpicillinbeta-Lactamase Inhibitors

Autor:innen und Institutionen

  • College of Pharmacy, Kangwon National University, Chuncheon-si, Republic of Korea.
  • Department of Systems Immunology, Kangwon National University, Chuncheon-si, Republic of Korea.
  • Department of Pharmacy, Kangwon National University Hospital, Chuncheon-si, Republic of Korea.
  • Department of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon-si, Republic of Korea.

ORCID-Profile: Woorim Kim

Förderung

  • 2024 Research Grant from Kangwon National University

Zitieren

APA

Moon, S., Hong, J., Lee, D. H., Kim, H. S., Nam, K. N., Jeon, Y. D., & Kim, W. (2025). Development of a predictive model for eosinophilia in patients treated with ampicillin/sulbactam or piperacillin/tazobactam. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70368

Vancouver

Moon S, Hong J, Lee DH, Kim HS, Nam KN, Jeon YD, et al. Development of a predictive model for eosinophilia in patients treated with ampicillin/sulbactam or piperacillin/tazobactam. British Journal of Clinical Pharmacology. 2025. doi:10.1002/bcp.70368

BibTeX
@article{Moon2025,
  author = {Moon, Sohyun and Hong, Jimin and Lee, Dae Hun and Kim, Hye Su and Nam, Ki Nam and Jeon, Yong Duk and Kim, Woorim},
  title = {Development of a predictive model for eosinophilia in patients treated with ampicillin/sulbactam or piperacillin/tazobactam},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1002/bcp.70368}
}
Kostenlos starten →